articles+ search results

741,592 articles+ results

View results as:
Number of results to display per page

2. Treating an Established Episode of Delirium in Palliative Care: Expert Opinion and Review of the Current Evidence Base With Recommendations for Future Development

3. Translational strategies for therapeutic development in nicotine addiction: Rethinking the conventional bench to bedside approach

4. Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or Δ9-tetrahydrocannabinol (THC)

5. Practical Assessment of Delirium in Palliative Care

6. Neurocognitive endophenotypes in schizophrenia: Modulation by nicotinic receptor systems

7. Ethical Challenges and Solutions Regarding Delirium Studies in Palliative Care

8. End-of-Life Delirium: Issues Regarding Recognition, Optimal Management, and the Role of Sedation in the Dying Phase

9. Delirium Diagnostic and Classification Challenges in Palliative Care: Subsyndromal Delirium, Comorbid Delirium-Dementia, and Psychomotor Subtypes

10. Clinical Practice Guidelines for Delirium Management: Potential Application in Palliative Care

11. Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence

12. Can antipsychotic treatment contribute to drug addiction in schizophrenia?

13. An Analytical Framework for Delirium Research in Palliative Care Settings: Integrated Epidemiologic, Clinician-Researcher, and Knowledge User Perspectives

14. ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: Implications for smoking and nicotine dependence

15. A Relational Ethical Approach to End-of-Life Delirium

16. Moyens non pharmacologiques et douleurs: quelle égalité d'accès pour les patients ? / Non-pharmacological methods and pain: is there equal access for patients?

17. Infirmiers ressource douleur et pratiques avancées: mythe ou réalité ? / Pain resource nurses and advanced practices: Myth or reality?

18. Symposium der Paul-Martini-Stiftung in verbindung mit der Deutschen Akademie der Naturforscher Leopoldina über Innovative Therapien in der Palliativmedizin / Symposium of the Paul Martini Foundation in Conjunction with the German Academy of Natural Scientists Leopoldina on Innovative Therapies in Palliative Care

19. Vigilance sanitaire et agences régionales de santé: quelle évaluation régionale du risque d'abus et d'addiction aux stupéfiants et aux psychotropes ? / Health vigilance, regional health agencies and regional evaluation of risk of drug abuse and psychotropic drug misuse in France

20. Plans de gestion des risques: bilan des premières expériences en addictovigilance / Risk management programms : results of first addictovigilance studies

21. The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function

22. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease

23. Successful methylphenidate treatment of early onset extreme obesity in a child with a melanocortin-4 receptor gene mutation and attention deficit/hyperactivity disorder

24. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease

25. Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: Advantages and limitations

26. Pharmacotherapy of Borderline Personality Disorder: A Systematic Review

27. Naturally-expressed nicotinic acetylcholine receptor subtypes

28. Mechanistic insights into nicotine withdrawal

29. Kinetic studies of drug―protein interactions by using peak profiling and high-performance affinity chromatography: Examination of multi-site interactions of drugs with human serum albumin columns

30. Innovative Therapien in der Hepatologie

31. Sex Differences in Animal Models of Depression and Antidepressant Response

32. Searching for new animal models of Alzheimer's disease

33. Opioid Detection in Maternal and Neonatal Hair and Meconium: Characterization of an At-Risk Population and Implications to Fetal Toxicology

34. Neurocognition in bipolar disorders—A closer look at comorbidities and medications

35. Major depression, cognitive dysfunction and Alzheimer's disease: Is there a link?

36. From vasotocin to stress and cognition

37. Development and validation of a HPLC method for the determination of sertraline and three non-chiral related impurities

38. Depression and Alzheimer's disease: Neurobiological links and common pharmacological targets

39. Cognitive impairment in major depression

40. Annual Meeting of the International Society for Neurostimulation

41. Annual Meeting of the International Society for Neurostimulation

42. Agreement Between the Fatty Acid Ethyl Ester HairTestfor Alcohol and Social Workers' Reports

44. Le récepteur opioïde delta: une nouvelle cible thérapeutique pour la douleur mais plus encore.. / The delta opioid receptor: a novel therapeutic target for pain and even more..

45. nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms

46. Time to Psychiatric Hospitalization in Patients With Bipolar Disorder Treated With a Mood Stabilizer and Adjunctive Atypical Antipsychotics: A Retrospective Claims Database Analysis

47. TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia

48. Sexual response models in women

49. Psychotherapeutic interventions for female sexual dysfunction

50. Progesterone, progestogens and psychosomatic health of the climacteric woman

51. Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition

52. Immobilized butyrylcholinesterase in the characterization of new inhibitors that could ease Alzheimer's disease

53. Does Effective Management of Sleep Disorders Reduce Substance Dependence?

54. Does Effective Management of Sleep Disorders Reduce Depressive Symptoms and the Risk of Depression?

55. Does Effective Management of Sleep Disorders Improve Pain Symptoms?

56. Age dependent nicotinic influences over dopamine neuron synaptic plasticity

57. A reversible model of the cognitive impairment associated with schizophrenia in monkeys: Potential therapeutic effects of two nicotinic acetylcholine receptor agonists

58. Youden test application in robustness assays during method validation

59. Vascular cognitive impairment in dementia

60. Validation of a reverse-phase high-performance liquid chromatography method for the determination of amino acids in gelatins by application of 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate reagent

61. Validation of a radial diffusive sampler for measuring occupational exposure to 1,3-butadiene

62. Validation of a high performance liquid chromatography-tandem mass spectrometry method for β-hydroxy fatty acids as environmental markers of lipopolysaccharide

63. Use of dichloromethane for preparative supercritical fluid chromatographic enantioseparations

64. Treatment, Monitoring, and Economic Outcomes of Venous Thromboembolism Among Hospitalized Patients in China

65. Tolerance to seizure induced by kainic acid is produced in a specific period of zebrafish development

66. Time Trends and Determinants of Pharmaceutical Expenditure in China (1990―2009)

67. The simultaneous systematic analysis approach for personalized management of cardiovascular diseases

68. The impact of size on particulate vaccine adjuvants

69. The Impact of the Urban Resident Basic Medical Insurance on Health Services Utilisation in China

70. Synthesis and application of immobilized polysaccharide-based chiral stationary phases for enantioseparation by high-performance liquid chromatography

71. Supported liquid membrane-protected molecularly imprinted beads for micro-solid phase extraction of sulfonamides in environmental waters

72. Superficially porous particles vs. fully porous particles for bonded high performance liquid chromatographic chiral stationary phases: Isopropyl cyclofructan 6

73. Stereoselective high-performance liquid chromatography and analytical method characterization of evacetrapib using a brush-type chiral stationary phase: A challenging isomeric separation requiring a unique eluent system

74. Sex and gender differences in the causes of dementia: A narrative review

75. Serotonergic modulation of zebrafish behavior: Towards a paradox

76. Separation of enantiomers on chiral stationary phase based on chicken α1-acid glycoprotein: Effect of silica particle diameters on column performance

77. Recent advances with a novel model organism: Alcohol tolerance and sensitization in zebrafish (Danio rerio)

78. Recent applications of carbon nanotube sorbents in analytical chemistry

79. Recent advances of ionic liquids and polymeric ionic liquids in capillary electrophoresis and capillary electrochromatography

80. Recent advances in the application of core-shell structured magnetic materials for the separation and enrichment of proteins and peptides

81. Recent advances in peptide-based subunit nanovaccines

82. Recent advances in chiral separation of amino acids using capillary electromigration techniques

83. Precision of the reportable result. Simultaneous optimisation of number of preparations and injections for sample and reference standard in quantitative liquid chromatography

84. Precision evaluation of chiral capillary electrophoretic methods in the context of inter-instrumental transfer: Constant current versus constant voltage application

85. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery

86. Pharmacological aspects of the antibiotics used for urological diagnostic procedures

87. Pharmaceutical Pricing: An Empirical Study of Market Competition in Chinese Hospitals

88. Overview of Cytopathology Procedures and Techniques

89. Octaproline, a conformationally flexible chiral selector in liquid chromatographic enantioseparation

90. Novel supports in chiral stationary phase development for liquid chromatography. Preparation, characterization and application of ordered mesoporous silica particles

91. Novel and sensitive reversed-phase high-pressure liquid chromatography method with electrochemical detection for the simultaneous and fast determination of eight biogenic amines and metabolites in human brain tissue

92. Neuropsychiatric aspects of dementia

93. Method validation strategies involved in non-targeted metabolomics

94. Method development and optimization on cinchona and chiral sulfonic acid-based zwitterionic stationary phases for enantiomer separations of free amino acids by high-performance liquid chromatography

95. Metal-organic framework UiO-66 coated stainless steel fiber for solid-phase microextraction of phenols in water samples

96. Liver Cytology

97. Ligand-receptor binding increments in enantioselective liquid chromatography

98. Investigation of two-dimensional high performance liquid chromatography approaches for reversed phase resolution of warfarin and hydroxywarfarin isomers

99. Interactions of non-charged tadalafil stereoisomers with cyclodextrins: Capillary electrophoresis and nuclear magnetic resonance studies

100. Inter-instrumental method transfer of chiral capillary electrophoretic methods using robustness test information


Books, media, physical & digital resources


Course- and topic-based guides to collections, tools, and services.